PubRank

Cezary Cybulski

Author PubWeight™ 109.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 2013 5.58
2 A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 2010 4.96
3 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013 4.35
4 GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 2013 3.42
5 Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet 2011 3.07
6 Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011 2.72
7 A range of cancers is associated with the rs6983267 marker on chromosome 8. Cancer Res 2008 2.43
8 The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res 2004 2.01
9 A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 2004 1.96
10 Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer. Breast Cancer Res 2012 1.81
11 Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet 2013 1.78
12 Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun 2013 1.73
13 Early radiation exposures and BRCA1-associated breast cancer in young women from Poland. Breast Cancer Res Treat 2008 1.59
14 Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 2011 1.51
15 A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet 2012 1.47
16 Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2010 1.41
17 Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer. J Clin Oncol 2013 1.26
18 Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2012 1.17
19 Phenocopies in breast cancer 1 (BRCA1) families: implications for genetic counselling. J Med Genet 2007 1.14
20 Germline 657del5 mutation in the NBS1 gene in breast cancer patients. Int J Cancer 2003 1.13
21 Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol 2011 1.12
22 A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer. Eur J Hum Genet 2003 1.08
23 CDKN2A common variants and their association with melanoma risk: a population-based study. Cancer Res 2005 1.08
24 The risk of breast cancer in women with a BRCA1 mutation from North America and Poland. Int J Cancer 2011 1.06
25 Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland. Breast Cancer Res Treat 2006 1.05
26 The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs. Hered Cancer Clin Pract 2005 1.04
27 MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk. Int J Cancer 2006 1.04
28 CDKN2A common variant and multi-organ cancer risk--a population-based study. Int J Cancer 2006 0.99
29 A low selenium level is associated with lung and laryngeal cancers. PLoS One 2013 0.99
30 Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet 2013 0.99
31 Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Hum Mutat 2012 0.98
32 Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma. Eur J Hum Genet 2006 0.97
33 The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland. Prostate 2013 0.97
34 CHEK2 mutation and hereditary breast cancer. J Clin Oncol 2007 0.96
35 Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology. Breast Cancer Res Treat 2008 0.95
36 Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization. Int J Cancer 2005 0.92
37 Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. BMC Cancer 2008 0.92
38 Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiol Biomarkers Prev 2013 0.92
39 A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer. Breast Cancer Res Treat 2008 0.92
40 The risk of gastric cancer in carriers of CHEK2 mutations. Fam Cancer 2013 0.91
41 Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer. Int J Cancer 2004 0.91
42 Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? Eur J Cancer 2008 0.90
43 Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer. Breast Cancer Res Treat 2011 0.90
44 Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res 2013 0.89
45 Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2014 0.89
46 A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2012 0.89
47 BRCA1 mutations and colorectal cancer in Poland. Fam Cancer 2010 0.89
48 A common nonsense mutation of the BLM gene and prostate cancer risk and survival. Gene 2013 0.89
49 A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population. Breast Cancer Res Treat 2007 0.89
50 Germline mutations in the CHEK2 kinase gene are associated with an increased risk of bladder cancer. Int J Cancer 2008 0.88
51 Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population. PLoS One 2011 0.88
52 The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population. Eur J Cancer Prev 2010 0.87
53 Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update. Breast Cancer Res Treat 2008 0.87
54 KRAS mutation testing in colorectal cancer as an example of the pathologist's role in personalized targeted therapy: a practical approach. Pol J Pathol 2012 0.87
55 CDKN2A-positive breast cancers in young women from Poland. Breast Cancer Res Treat 2006 0.87
56 Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk. Breast Cancer Res Treat 2008 0.87
57 CHEK2 mutations and HNPCC-related colorectal cancer. Int J Cancer 2010 0.87
58 Pathology of breast cancer in women with constitutional CHEK2 mutations. Breast Cancer Res Treat 2005 0.86
59 Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families. Mol Biol Rep 2013 0.86
60 The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer. Breast Cancer Res Treat 2012 0.86
61 CHEK2 germline mutations correlate with recurrence rate in patients with superficial bladder cancer. Ann Acad Med Stetin 2008 0.85
62 Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population. Mol Biol Rep 2014 0.85
63 Variant alleles of the CYP1B1 gene are associated with colorectal cancer susceptibility. BMC Cancer 2010 0.84
64 Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium. PLoS One 2011 0.83
65 CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland. Fam Cancer 2010 0.83
66 Exploring the link between germline and somatic genetic alterations in breast carcinogenesis. PLoS One 2010 0.83
67 Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin. Melanoma Res 2003 0.83
68 Molecular basis of inherited predispositions for tumors. Acta Biochim Pol 2002 0.83
69 CYP1B1 and predisposition to breast cancer in Poland. Breast Cancer Res Treat 2007 0.83
70 PARS PLANA VITRECTOMY IN ADVANCED CASES OF VON HIPPEL-LINDAU EYE DISEASE. Retina 2016 0.82
71 Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunol Res 2014 0.82
72 Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene. Breast Cancer Res Treat 2006 0.81
73 BARD1 and breast cancer in Poland. Breast Cancer Res Treat 2007 0.81
74 Low prevalence of CDKN2A/ARF mutations among early-onset cancers of breast, pancreas and malignant melanoma in Poland. Eur J Cancer Prev 2008 0.81
75 Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe. Fam Cancer 2015 0.81
76 A simple method of investigating mutations in CHEK2 by DHPLC: a study of the German populations of Saxony, Saxony-Anhalt, and Thuringia. Cancer Genet Cytogenet 2010 0.80
77 Genetic heterogeneity of 8q24 region in susceptibility to cancer. J Natl Cancer Inst 2009 0.80
78 Rarity of germline 1100delC mutation in CHK2 in patients with malignant melanoma of the skin. Melanoma Res 2004 0.80
79 Antigens HLA-G, sHLA- G and sHLA- class I in reproductive failure. Folia Histochem Cytobiol 2007 0.80
80 The presence of prostate cancer at biopsy is predicted by a number of genetic variants. Int J Cancer 2013 0.79
81 Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array. Br J Cancer 2016 0.78
82 Association of MMP8 gene variation with an increased risk of malignant melanoma. Melanoma Res 2011 0.78
83 Low-risk Genes and Multi-organ Cancer Risk in the Polish Population. Hered Cancer Clin Pract 2006 0.78
84 Case report of a woman with monoclonal gammapathy and papillary thyroid carcinoma, diagnosed because of detection of CHEK2 (I157T) mutation in genetic examinations. Endokrynol Pol 2010 0.78
85 Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res 2014 0.77
86 The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men. Eur J Cancer Prev 2015 0.77
87 Breast cancer susceptibility genes. J BUON 2007 0.77
88 Optimizing recruitment to a prostate cancer surveillance program among male BRCA1 mutation carriers: invitation by mail or by telephone. Hered Cancer Clin Pract 2013 0.77
89 Population screening for cancer family syndromes in the west pomeranian region of poland. Hered Cancer Clin Pract 2006 0.77
90 A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet. Hered Cancer Clin Pract 2006 0.76
91 Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations. Breast Cancer Res Treat 2014 0.75
92 Corrigendum: Germline RECQL mutations are associated with breast cancer susceptibility. Nat Genet 2016 0.75
93 A case of carotid body paraganglioma and haemangioblastoma of the spinal cord in a patient with the N131K missense mutation in the VHL gene. Neurol Sci 2011 0.75
94 BRCA1 founder mutations compared to ovarian cancer in Belarus. Fam Cancer 2014 0.75
95 Coverage of the genetic background of breast cancer in the polish population. Hered Cancer Clin Pract 2006 0.75
96 DNA testing for variants conferring low or moderate increase in the risk of cancer. Hered Cancer Clin Pract 2008 0.75
97 Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers. J Appl Genet 2003 0.75
98 [HLA-G alleles and risk of early pregnancy loss]. Ann Acad Med Stetin 2008 0.75
99 Modest association of malignant melanoma with the rs910873 and rs1885120 markers on chromosome 20: a population-based study. Melanoma Res 2010 0.75
100 Genotyping by induced Förster Resonance Energy Transfer(iFRET) mechanism and simultaneous mutation scanning. Hum Mutat 2013 0.75
101 Retinal function in the von Hippel-Lindau disease. Doc Ophthalmol 2003 0.75
102 Selenium as marker for cancer risk and prevention. Pol Przegl Chir 2012 0.75